<ѻý>Who Should Pay to Clean Up 'Forever Chemicals'?ѻý> Not us, representatives of water utilities and landfills say at a Senate hearing Mar 20, 2024
<ѻý>Mutation Linked to Increased Risk of Prostate Cancer Mortalityѻý> Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele Mar 20, 2024
<ѻý>Lenvatinib-Pembrolizumab Combo Misses on Survival in Endometrial Cancer Trialѻý> Combination in first-line fails to improve progression-free, overall survival versus chemotherapy Mar 20, 2024
<ѻý>Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicinѻý> Dose-dependent increase regardless of age at treatment or chest radiotherapy Mar 19, 2024
<ѻý>Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancerѻý> Use of the PARP inhibitor improved PFS by 19.4 months versus placebo in phase II study Mar 19, 2024
<ѻý>EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Banѻý> New rule would prohibit chrysotile asbestos Mar 19, 2024
<ѻý>Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidenceѻý> Growing body of data suggest it can be safe and effective in low-risk disease, says expert Mar 18, 2024
<ѻý>Novel Drug-Device Shows Efficacy for High-Grade Cervical Lesionsѻý> Response rate doubles with the noninvasive treatment versus placebo Mar 18, 2024
<ѻý>How Often Should Immunocompromised People Get a COVID Booster?ѻý> Experts say about every 6 months, but that should be individualized Mar 18, 2024
<ѻý>Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docsѻý> Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says Mar 18, 2024
<ѻý>Laparoscopy Quickly Abandoned in Early Cervical Cancer After LACC Resultsѻý> MIS roughly halved in the 2 years following the study results, national dataset shows Mar 18, 2024
<ѻý>Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancerѻý> Dostarlimab and pembrolizumab regimens should be incorporated into practice "as of yesterday" Mar 17, 2024
<ѻý>Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancerѻý> Novel ADC targeting CDH6 achieves response in nearly 50% of patients Mar 17, 2024
<ѻý>FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myelomaѻý> Cilta-cel, ide-cel win support despite concerns about early mortality risk Mar 16, 2024
<ѻý>Delta-8 THC Use Common in Teens; New Drug-Coated Balloon for Blocked Stentsѻý> Also in TTHealthWatch: new screening methods for colorectal cancer Mar 16, 2024 podcast
<ѻý>EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Riskѻý> Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
<ѻý>FDA Approves First CAR-T for Chronic Lymphocytic Leukemiaѻý> Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
<ѻý>New PD-1 Inhibitor Approved for Esophageal Cancerѻý> Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months Mar 15, 2024
<ѻý>FDA Panel Endorses Imetelstat for MDS-Related Anemiaѻý> By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
<ѻý>Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myelomaѻý> FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting Mar 14, 2024
<ѻý>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'ѻý> News, features, and commentary about cancer-related issues Mar 14, 2024
<ѻý>Rheumatologist Found Dead; How COVID Changed Lives; Olivia Munn's Breast Cancerѻý> Health news and commentary from around the Web gathered by ѻý staff Mar 14, 2024
<ѻý>Olivia Munn Reveals Breast Cancer Diagnosis and Double Mastectomyѻý> A high Breast Cancer Risk Assessment Score led to imaging and a biopsy Mar 14, 2024
<ѻý>Novel CAR-T for Glioblastoma Induced 'Dramatic' Responses in Early Trialѻý> In three patients, one-time infusion of CARv3-TEAM-E T cells resulted in rapid tumor regression Mar 13, 2024
<ѻý>Noninvasive Screening Tests Show Promise for Catching Colorectal Cancerѻý> Could these tests help to increase the number of people who undergo screening? Mar 13, 2024
<ѻý>FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemiaѻý> Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
<ѻý>Sickle Cell Pain Hospitalizations Rose After CDC's Opioid Recsѻý> Agency's 2016 guidance may have contributed to reduced access to opioids, and more pain Mar 11, 2024
<ѻý>Banning Gain-of-Function Research Would Do Far More Harm Than Goodѻý> A House-passed bill could stifle the potential for revolutionary medical advancements Mar 11, 2024
<ѻý>Knowing When to Start, Knowing When to Stopѻý> Discussions about screening recommendations can be difficult, but they're worth having Mar 11, 2024
<ѻý>First-Line Nivolumab Plus Chemo Approved for Bladder Cancerѻý> Combination reduced risk of death by 22% Mar 07, 2024
<ѻý>First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggestsѻý> Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
<ѻý>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertuѻý> News, features, and commentary about cancer-related issues Mar 07, 2024
<ѻý>Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patientsѻý> Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
<ѻý>FDA OKs First Interchangeable Biosimilars for Denosumabѻý> New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
<ѻý>King Charles' Cancer Diagnosis Highlights Long Wait Times Across the Pondѻý> Survival for common cancers in the U.K. consistently lags behind Mar 06, 2024
<ѻý>IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubtѻý> "Every month that you're not pregnant feels like grief" Mar 05, 2024
<ѻý>All-Oral AML Regimen Shows Promise for Older, Unfit Patientsѻý> Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease Mar 05, 2024
<ѻý>More Evidence Linking H. Pylori Infection to Colorectal Cancerѻý> Increased CRC incidence and mortality, significantly reduced by infection treatment Mar 05, 2024
<ѻý>Novel Therapy Promising for Radiation-Induced Oral Mucositisѻý> No patient with head and neck cancer developed a severe case during 7 weeks of treatment Mar 04, 2024
<ѻý>Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancerѻý> Few responses with or without guidance in small first step for "personalized" treatment Mar 04, 2024